JACC: Cardiovascular Imaging
Effusive-Constrictive Pericarditis After PericardiocentesisIncidence, Associated Findings, and Natural History
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article.
Author + information
- Received April 18, 2017
- Revision received June 19, 2017
- Accepted June 22, 2017
- Published online April 2, 2018.
Article Versions
- previous version (September 13, 2017 - 11:04).
- You are viewing the most recent version of this article.
Author Information
- Kye Hun Kim, MDa,b,
- William R. Miranda, MDa,
- Larry J. Sinak, MDa,
- Faisal F. Syed, MBChBa,
- Rowlens M. Melduni, MDa,
- Raul E. Espinosa, MDa,
- Garvan C. Kane, MDa and
- Jae K. Oh, MDa,∗ (oh.jae{at}mayo.edu)
- aDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
- bDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea
- ↵∗Address for correspondence:
Dr. Jae K. Oh, Department of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
Graphical abstract
Abstract
Objectives This study sought to investigate the incidence, associated findings, and natural history of effusive-constrictive pericarditis (ECP) after pericardiocentesis.
Background ECP is characterized by the coexistence of tense pericardial effusion and constriction of the heart by the visceral pericardium. Echocardiography is currently the main diagnostic tool in the assessment of pericardial disease, but limited data have been published on the incidence and prognosis of ECP diagnosed by echo-Doppler.
Methods A total of 205 consecutive patients undergoing pericardiocentesis at Mayo Clinic, Rochester, Minnesota, were divided into 2 groups (ECP and non-ECP) based on the presence or absence of post-centesis echocardiographic findings of constrictive pericarditis. Clinical, laboratory, and imaging characteristics were compared.
Results ECP was subsequently diagnosed in 33 patients (16%) after pericardiocentesis. Overt clinical cardiac tamponade was present in 52% of ECP patients and 36% of non-ECP patients (p = 0.08). Post-procedure hemopericardium was more frequent in the ECP group (33% vs. 13%; p = 0.003), and a higher percentage of neutrophils and lower percentage of monocytes were noted on pericardial fluid analysis in those patients. Clinical and laboratory findings were otherwise similar. Baseline early diastolic mitral septal annular velocity was significantly higher in the ECP group. Before pericardiocentesis, respiratory variation of mitral inflow velocity, expiratory diastolic flow reversal of hepatic vein, and respirophasic septal shift were significantly more frequent in the ECP group. Fibrinous or loculated effusions were also more frequently observed in the ECP group. Four deaths occurred in the ECP group; all 4 patients had known malignancies. During median follow-up of 3.8 years (interquartile range: 0.5 to 8.3 years), only 2 patients required pericardiectomy for persistent constrictive features and symptoms.
Conclusions In a large cohort of unselected patients undergoing pericardiocentesis, 16% were found to have ECP. Pre-centesis echocardiographic findings might identify such patients. Long-term prognosis in those patients remains good, and pericardiectomy was rarely required.
Footnotes
All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received April 18, 2017.
- Revision received June 19, 2017.
- Accepted June 22, 2017.
- 2018 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.